New systems that combine Raman spectroscopy with automated imaging support the efficient gathering of such data, including information concerning size and shape distributions for individual components ...
PRINCETON, N.J., March 4, 2026 /PRNewswire/ -- Kenox Pharmaceuticals Inc. (Kenox), a fast‑growing contract development and manufacturing organization (CDMO) dedicated exclusively to Orally Inhaled and ...
SPH Sine will use Marinomed's proprietary Marinosolv technology to dissolve its active pharmaceutical ingredient (API) in an orally inhaled and nasal drug product (OINDP) formulation The developed ...
Malvern Panalytical will showcase the new Morphologi G3-ID particle characterization system at Drug Delivery to the Lungs 23, which takes place from 5 – 7 Dec 2012 in Edinburgh, Scotland. The company ...
The challenge of developing orally inhaled nasal drug products (OINDPs) is complicated by the interplay between drug-delivery devices and formulation. PharmTech: What are some of the challenges in ...
Partnership strengthens Strides' pipeline of nasal spray products across diverse therapeutic areas Kenox to provide formulation and development expertise in Orally Inhaled and Nasal Drug Products ...
LONDON--(BUSINESS WIRE)--Intertek, the leading quality solutions provider to industries worldwide, announces that it has acquired Melbourn Scientific Ltd (“Melbourn”), a leading provider of analysis ...
It has expertise in all aspects of characterisation of orally inhaled and intra-nasal products (OINDP) and transdermal devices in addition to services for conventionally delivered medicines. There is ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results